Syros Pharmaceuticals Inc. buy BiotechBee
Start price
04.12.23
/
60%
€2.67
Target price
30.11.25
€4.00
Performance (%)
-47.57%
End price
08.09.24
€1.40
Summary
This prediction ended on 08.09.24 with a price of €1.40. The BUY prediction by BiotechBee for Syros Pharmaceuticals Inc. performed very badly with a performance of -47.57%. BiotechBee has a follow-up prediction for Syros Pharmaceuticals Inc. where he still thinks Syros Pharmaceuticals Inc. is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Syros Pharmaceuticals Inc. | 2.874% | 2.874% |
iShares Core DAX® | 3.523% | 2.930% |
iShares Nasdaq 100 | 1.026% | 2.688% |
iShares Nikkei 225® | -0.063% | -0.442% |
iShares S&P 500 | 0.557% | 1.759% |
According to BiotechBee what are the pros and cons of Syros Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Syros Pharmaceuticals Inc diskutieren
Buy mit Kursziel 4,0
In the thread Trading Syros Pharmaceuticals Inc
Buy beendet
Current prediction by BiotechBee for Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.79
29.09.24
29.09.24
€3.00
31.05.27
31.05.27
-
27.09.24
27.09.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.40
08.09.24
08.09.24
€5.50
30.06.27
30.06.27
27.86%
29.09.24
29.09.24
Could be very worthwhile Investment >20% year
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.68
24.06.23
24.06.23
€4.00
31.12.25
31.12.25
36.94%
01.10.23
01.10.23
Could be very worthwhile Investment >20% year